INVO Bioscience, Inc. (IVF): Debts to Book Capitalization

INVO Fertility Inc (IVF) utilizes a fabless production model for bioelectronic incubators through US partners. Management is implementing natural infertility treatment methods, while assembly lines are undergoing upgrades to leak detection control systems. This chart of the total debt-to-equity ratio helps assess financial stability, while 0.24 shows the value of this parameter, defining the boundaries of the business's fundamental norm.

INVO Fertility Inc - IVF Debts to Book Capitalization (period 04/29/2025 - 10/28/2026)

Institutional capital assesses the attractiveness of INVO Fertility Inc (IVF) through the lens of financial stability. This indicator compares total liabilities to the book value of equity, measuring the business's degree of dependence on borrowed funds. By analyzing the current ratio of debt to book capitalization, investors determine the balance between default risk and expansion rates. Stable incubator deliveries minimize operational disruptions, strengthening the asset's foundation. Low leverage confirms the high reliability of INVO Fertility Inc (IVF).

Competitors of INVO Fertility Inc

Boston Scientific - Debts to Book Capitalization|Debt to Book Value edwards.com EW|Debts to Book Capitalization RMD (ResMed)|PODD - Debts to Net Assets|ZBH: Debts to Book Capitalization|COO (CooperSurgical) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Align Technology, Inc.|Debt to Book Capitalization Ratio globusmedical.com|TMDX (TransMedics Organ Care System) - Debts to Book Capitalization|Debts to Net Assets Alphatec Holdings ATEC|Artivion Inc (AORT) - Debt to Book Value|Debts to Book Capitalization Ratio Enovis Inc. ENOV|IART (Integra LifeSciences) - Debts to Book Capitalization|ESTA - Debts to Book Value|Debts to Book Capitalization Beta Bionics|Debt to Book Value Ratio IRADIMED Corp|EMBC - Debt to Book Value|Debt to Net Assets Ratio TNDM|Debt to Book Capitalization Ratio AXGN (AxoGen, Inc.)|Debt to Book Value si-bone.com (SIBN)|OFIX: Debts to Book Capitalization|Debts to Book Value Bioventus Inc BVS|OrthoPediatrics Inc. (KIDS) - Debts to Book Capitalization|TMCI - Debt to Book Value Ratio|Strata Critical Medical Inc - Debts to Book Capitalization|carlsmed.com (CARL) - Debts to Net Assets|Debts to Book Capitalization RXST|Debt to Book Value ClearPoint|Debts to Book Capitalization STXS|Debts to Book Capitalization STIM (Neuronetics, Inc)|Debt to Book Capitalization Ratio Sight Sciences, Inc. SGHT|OBIO - Debt to Book Capitalization Ratio|Debt to Book Value Anika (ANIK)|NSPR - Debt to Net Assets Ratio|Debts to Book Capitalization ZJYL|VANI (Vivani Medical) - Debts to Book Value|Xtant Medical Holdings, Inc. - Debt to Book Capitalization Ratio|Debt to Net Assets n1mtc.com (NMTC)|Debt to Book Value MODD|Debts to Book Capitalization Myomo Inc. (MYO)|Debts to Book Capitalization COCH|Vivos Therapeutics Inc - Debts to Net Assets|Debt to Book Capitalization Ratio enVVeno Medical|SINT: Debts to Book Capitalization Ratio|TNON (Tenon Medical) - Debt to Book Capitalization Ratio|ReWalk Robotics (LFWD) - Debt to Book Value|Debts to Book Capitalization AMIX (Autonomix Medical Inc.)|Debts to Book Value BBLG|Debt to Book Capitalization Ratio Axonics, Inc. AXNX|Debt to Book Value Ratio biolase.com BIOL|Debt to Book Value Dynatronics (DYNT)|Debt to Book Capital Paragon 28 Inc. FNA|Debts to Book Capitalization INVO (INVO Bio)